journal article·2014-04-22

Cryptic Epitopes of Albumin Determine Mononuclear Phagocyte System Clearance of Nanomaterials

Gysell M. Mortimer, Neville J. Butcher, Anthony W. Musumeci, Zhou J. Deng, Darren J. Martin, Rodney F. Minchin

ACS Nano· Volume 8· Issue 4
Publisher page

Abstract

While plasma proteins can influence the physicochemical properties of nanoparticles, the adsorption of protein to the surface of nanomaterials can also alter the structure and function of the protein. Here, we show that plasma proteins form a hard corona around synthetic layered silicate nanoparticles (LSN) and that one of the principle proteins is serum albumin. The protein corona was required for recognition of the nanoparticles by scavenger receptors, a major receptor family associated with the mononuclear phagocyte system (MPS). Albumin alone could direct nanoparticle uptake by human macrophages, which involved class A but not class B scavenger receptors. Upon binding to LSN, albumin unfolded to reveal a cryptic epitope that could also be exposed by heat denaturation. This work provides an understanding of how albumin, and possibly other proteins, can promote nanomaterial recognition by the MPS without albumin requiring chemical modification for scavenger receptor recognition. These findings also demonstrate an additional function for albumin in vivo.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Protein Interaction Studies and Fluorescence Analysis · Polymer Surface Interaction Studies

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

School of Biomedical Sciences and ‡Australian Institute for Bioengineering and Nanotechnology, University of Queensland, Brisbane, Queensland, 4072, Australia

Funding

National Health and Medical Research Council

References (60)

Show source-provided references
1. Ernsting M. J. · J. Controlled Release · 2013 · 172 · 78210.1016/j.jconrel.2013.09.013 ↗
2. Hume D. A. · Curr. Opin. Immunol. · 2006 · 18 · 4910.1016/j.coi.2005.11.008 ↗
3. Minchin R. F. · Endocrinology · 2010 · 151 · 47410.1210/en.2009-1012 ↗
4. Caron W. P. · Clin. Pharmacol. Ther. · 2012 · 91 · 80210.1038/clpt.2012.12 ↗
5. Moghimi S. M. · Crit. Rev. Ther. Drug Carrier Syst. · 2001 · 18 · 52710.1615/CritRevTherDrugCarrierSyst.v18.i6.30 ↗
6. Opanasopit P. · Crit. Rev. Ther. Drug Carrier Syst. · 2002 · 19 · 19110.1615/CritRevTherDrugCarrierSyst.v19.i3.10 ↗
7. Fernandez-Urrusuno R. · J. Biomed. Mater. Res. · 1996 · 31 · 40110.1002/(SICI)1097-4636(199607)31:3<401::AID-JBM15>3.0.CO;2-L ↗
8. Nagayama S. · Int. J. Pharm. · 2007 · 342 · 21510.1016/j.ijpharm.2007.04.036 ↗
9. Nishimori H. · Eur. J. Pharm. Biopharm. · 2009 · 72 · 49610.1016/j.ejpb.2009.02.005 ↗
10. Jones S. W. · J. Clin. Invest. · 2013 · 123 · 306110.1172/JCI66895 ↗
11. Dams E. T. · J. Pharmacol. Exp. Ther. · 2000 · 292 · 107110.1016/S0022-3565(24)35391-1 ↗
12. Ishida T. · J. Controlled Release · 2006 · 115 · 24310.1016/j.jconrel.2006.08.001 ↗
13. Kaminskas L. M. · J. Pharm. Sci. · 2011 · 100 · 506910.1002/jps.22682 ↗
14. Shiraishi K. · J. Controlled Release · 2013 · 165 · 18310.1016/j.jconrel.2012.11.016 ↗
15. Walczyk D. · J. Am. Chem. Soc. · 2010 · 132 · 576110.1021/ja910675v ↗
16. Monopoli M. P. · Nat. Nanotechnol. · 2011 · 6 · 1110.1038/nnano.2010.267 ↗
17. Monopoli M. P. · Nat. Nanotechnol. · 2012 · 7 · 77910.1038/nnano.2012.207 ↗
18. Furumoto K. · J. Controlled Release · 2002 · 83 · 8910.1016/S0168-3659(02)00196-7 ↗
19. Ogawara K. · J. Controlled Release · 2004 · 100 · 45110.1016/j.jconrel.2004.07.028 ↗
20. Oberdorster G. · J. Intern. Med. · 2010 · 267 · 8910.1111/j.1365-2796.2009.02187.x ↗
21. Chun A. L. · Nat. Nanotechnol. · 2009 · 4 · 79010.1038/nnano.2009.359 ↗
22. Patel H. A. · Bull. Mater. Sci. · 2006 · 29 · 13310.1007/BF02704606 ↗
23. Pavlidou S. · Prog. Polym. Sci. · 2008 · 33 · 111910.1016/j.progpolymsci.2008.07.008 ↗
24. Osman A. F. · Macromolecules · 2012 · 45 · 19810.1021/ma202189e ↗
25. Andriani Y. · J. Colloid Interface Sci. · 2013 · 409 · 7210.1016/j.jcis.2013.07.055 ↗
26. Andriani Y. · Acta Biomater. · 2013 · 9 · 830810.1016/j.actbio.2013.05.021 ↗
27. Raynal I. · Invest. Radiol. · 2004 · 39 · 5610.1097/01.rli.0000101027.57021.28 ↗
28. Dutta D. · Toxicol. Sci. · 2007 · 100 · 30310.1093/toxsci/kfm217 ↗
29. Jansen R. W. · Biochem. Biophys. Res. Commun. · 1991 · 180 · 2310.1016/S0006-291X(05)81249-5 ↗
30. Kamps J. A. · Proc. Natl. Acad. Sci. U.S.A. · 1997 · 94 · 1168110.1073/pnas.94.21.11681 ↗
31. Demoy M. · Life Sci. · 1999 · 64 · 132910.1016/S0024-3205(99)00068-5 ↗
32. Hamblin M. R. · Photochem. Photobiol. · 2000 · 72 · 53310.1562/0031-8655(2000)072<0533:SRTPT>2.0.CO;2 ↗
33. Landsiedel R. · Arch. Toxicol. · 2012 · 86 · 102110.1007/s00204-012-0858-7 ↗
34. Wagner H. D. · Nat. Nanotechnol. · 2007 · 2 · 74210.1038/nnano.2007.401 ↗
35. Journeay W. S. · Integr. Environ. Assess. Manage. · 2008 · 4 · 12810.1002/ieam.5630040117 ↗
36. Best J. P. · Adv. Healthcare Mater. · 2012 · 1 · 3510.1002/adhm.201100012 ↗
37. Canton I. · Chem. Soc. Rev. · 2012 · 41 · 271810.1039/c2cs15309b ↗
38. Wills E. J. · Nat. New. Biol. · 1972 · 240 · 5810.1038/newbio240058a0 ↗
39. He J. Q. · Mol. Immunol. · 2008 · 45 · 404110.1016/j.molimm.2008.07.011 ↗
40. Triglia R. P. · Mol. Immunol. · 1980 · 17 · 74110.1016/0161-5890(80)90144-3 ↗
41. Larsericsdotter H. · J. Colloid Interface Sci. · 2005 · 289 · 2610.1016/j.jcis.2005.03.064 ↗
42. Walkey C. D. · Chem. Soc. Rev. · 2012 · 41 · 278010.1039/C1CS15233E ↗
43. Rocker C. · Nat. Nanotechnol. · 2009 · 4 · 57710.1038/nnano.2009.195 ↗
44. Martinez V. G. · Pharmacol. Rev. · 2011 · 63 · 96710.1124/pr.111.004523 ↗
45. Matveev S. · J. Lipid Res. · 1999 · 40 · 164710.1016/S0022-2275(20)33410-6 ↗
46. Haberland M. E. · Proc. Natl. Acad. Sci. U.S.A. · 1985 · 82 · 269310.1073/pnas.82.9.2693 ↗
47. Lysko P. G. · J. Pharmacol. Exp. Ther. · 1999 · 289 · 127710.1016/S0022-3565(24)38270-9 ↗
48. Flora K. · Biophys. J. · 1998 · 75 · 108410.1016/S0006-3495(98)77598-8 ↗
49. Dockal M. · J. Biol. Chem. · 2000 · 275 · 304210.1074/jbc.275.5.3042 ↗
50. Castillo E. J. · Biomaterials · 1984 · 5 · 31910.1016/0142-9612(84)90029-2 ↗
51. Sivaraman B. · Langmuir · 2009 · 25 · 305010.1021/la8036814 ↗
52. Smith J. R. · Langmuir · 2009 · 25 · 457110.1021/la802955w ↗
53. Schnitzer J. E. · J. Biol. Chem. · 1992 · 267 · 2454410.1016/S0021-9258(18)35799-5 ↗
54. Schnitzer J. E. · J. Biol. Chem. · 1993 · 268 · 756210.1016/S0021-9258(18)53212-9 ↗
55. Ghinea N. · J. Cell Biol. · 1988 · 107 · 23110.1083/jcb.107.1.231 ↗
56. Deng Z. J. · Nat. Nanotechnol. · 2011 · 6 · 3910.1038/nnano.2010.250 ↗
57. Dejager S. · Arterioscler. Thromb. · 1993 · 13 · 37110.1161/01.ATV.13.3.371 ↗
58. Beppu M. · Biol. Pharm. Bull. · 1994 · 17 · 3910.1248/bpb.17.39 ↗
59. Rhainds D. · Eur. J. Biochem. · 1999 · 261 · 22710.1046/j.1432-1327.1999.00264.x ↗
60. Horiuchi S. · J. Biol. Chem. · 1985 · 260 · 47510.1016/S0021-9258(18)89757-5 ↗